A pooled analysis of bone marrow micrometastasis in breast cancer

New England Journal of Medicine

Volumn 353, Issue 8, 2005, Pages 793-802

  Braun, Stephan ^a   Vogl, Florian D ^b   Naume, Bjørn ^c   Janni, Wolfgang ^d   Osborne, Michael P ^e   Coombes, R Charles ^f   Schlimok, Günter ^g   Diel, Ingo J ^h   Gerber, Bernd ⁱ   Gebauer, Gerhard ^j   Pierga, Jean Yves ^k   Marth, Christian ^a   Oruzio, Daniel ^g   Wiedswang, Gro ^c   Solomayer, Erich Franz ^h   Kundt, Günther ⁱ   Strobl, Barbara ^d   Fehm, Tanja ^j   Wong, George Y C ^l   Bliss, Judith ^m   Vincent Salomon, Anne ^k   Pantel, Klaus ⁿ   more..

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b General Hospital   (Italy)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF MUNICH   (Germany)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g KLINIKUM AUGSBURG   (Germany)

^h UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

ⁱ ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^j UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^k INSTITUT CURIE   (France)

^l WEILL CORNELL MEDICAL CENTER   (United States)

^m INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁿ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MARROW METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; BONE MARROW CANCER; BREAST TUMOR; CLINICAL TRIAL; DISEASE FREE SURVIVAL; META ANALYSIS; METASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

BONE MARROW NEOPLASMS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 23944466427     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa050434     Document Type: Article

References (27)

1. Fisher B, Fisher ER, Guzman C, Copeland CE, Caceres E. The dissemination of subcutaneously inoculated tumor cell suspensions. Arch Surg 1969;98:347-51.
2. Braun S, Cevatli BS, Assemi C, et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of nodenegative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001;19:1468-75.
3. Gerber B, Krause A, Muller H, et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 2001;19:960-71.
4. Woelfle U, Cloos J, Sauter G, et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003;63:5679-84.
5. Klein CA, Blankenstein TJF, Schmidt-Kittler O, et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002;360:683-9.
6. Braun S, Naume B. Circulating and disseminated tumor cells. J Clin Oncol 2005;23:1623-6.
7. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4:448-56.
8. Pierga J-Y, Bonneton C, Vincent-Salomon A, et al. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 2004;10:1392-400.
9. Wiedswang G, Borgen E, Karesen R, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 2003;21:3469-78.
10. Gebauer G, Fehm T, Merkle E, Beck EP, Lang N, Jager W. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol 2001;19:3669-74.
11. Braun S, Pantel K, Müller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-33. [Erratum, N Engl J Med 2000;343:308.]
12. Mansi JL, Gogas H, Bliss JM, Gazet JC, Berger U, Coombes RC. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 1999;354:197-202.
13. Diel IJ, Kaufmann M, Costa SD, et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996;88:1652-8.
14. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991;9:1749-56.
15. Wong GYC, Yu QQ, Osborne MP. Bone marrow micrometastasis is a significant predictor of long-term relapse-free survival for breast cancer by a non-proportional hazards model. Breast Cancer Res Treat 2003;82:Suppl 1:S99. abstract.
16. Osborne M, Wong G, Asina S, Old LJ, Cote RJ, Rosen PP. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res 1991;51:2706-9.
17. DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med 1996;15:1237-48.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc [A] 1972;135:185-206.
20. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
21. Collett D. Modelling survival data in medical research. 2nd ed. Boca Raton, Fla.: Chapman & Hall/CRC, 2003.
22. Grambsch P, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
23. Hunink MG, Wong JB. Meta-analysis of failure-time data with adjustment for covariates. Med Decis Making 1994;14:59-70.
24. Clarke MJ, Stewart LA. Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? BMJ 1994;309:1007-10.
25. Gangnus R, Langer S, Breit E, Pantel K, Speicher MR. Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients. Clin Cancer Res 2004;10:3457-64.
26. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 2003;100:7737-42.
27. Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-84.